ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Warszawa, Mazowieckie

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Ovarian Cancer
Breast Cancer
Ovarian Epithelial Carcinoma
Triple Negative Breast Cancer
Adenocarcinoma

Endometrial Cancer trials near Warszawa, Mazowieckie, POL:

Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)

Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...

Enrolling
Endometrial Cancer
Drug: Paclitaxel
Drug: Doxorubicin

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Warszawa, Mazowieckie, Poland and 121 other locations

study is designed to evaluate the efficacy, safety, and pharmacokinetics of giredestrant monotherapy in participants with Grade 1 endometrioid endometrial...

Enrolling
Endometrial Cancer
Drug: Giredestrant

Phase 2

Roche
Roche

Warszawa, Poland and 18 other locations

This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have ...

Enrolling
Endometrial Cancer
Drug: Navtemadlin Placebo
Drug: Navtemadlin

Phase 2, Phase 3

Kartos Therapeutics
Kartos Therapeutics

Warsaw, Poland and 82 other locations

participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....

Active, not recruiting
Neoplasms
Drug: Carboplatin
Drug: Paclitaxel

Phase 3

Tesaro
Tesaro

Warszawa, Poland and 162 other locations

choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...

Active, not recruiting
Endometrial Neoplasms
Drug: Pembrolizumab
Drug: Doxorubicin

Phase 3

Eisai
Eisai

Warszawa, Mazowieckie, Poland and 168 other locations

TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Com...

Enrolling
Endometrial Cancer
Gastric Cancer
Drug: Carboplatin
Drug: Leucovorin LV

Phase 2

AstraZeneca
AstraZeneca

Warszawa, Poland and 92 other locations

First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas. CPI-0209...

Enrolling
Endometrial Cancer
Lymphoma, T-Cell
Drug: CPI-0209

Phase 1, Phase 2

Constellation Pharmaceuticals

Warsaw, Poland and 49 other locations

The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, wit...

Active, not recruiting
Endometrial Neoplasms
Drug: Placebo for pembrolizumab
Drug: Cisplatin (as radiosensitizer)

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Warszawa, Mazowieckie, Poland and 230 other locations

The purpose of the study is to determine to evaluate safety and tolerability of CPL304110 when administered once daily to adults with advanced solid...

Enrolling
Endometrial Cancer
Bladder Cancer
Drug: CPL304110

Phase 1

Celon Pharma

Warsaw, Poland and 6 other locations

In this study, participants with multiple types of advanced (unresectable and/or metastatic) solid tumors who have progressed on standard of care the...

Enrolling
Anal Cancer
Salivary Cancer
Biological: pembrolizumab

Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Warsaw, Poland and 22 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems